Long-term survival after initial hospital admission for peripheral arterial disease in the lower extremities

BMC Cardiovascular Disorders

Volumn 9, Issue , 2009, Pages 43-

  Vaartjes, I ^a   de Borst, G J ^a   Reitsma, J B ^b   de Bruin, A ^c   Moll, F L ^a   Grobbee, D E ^a   Bots, M L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c STATISTICS NETHERLANDS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTERY DISEASE; ARTICLE; AWARENESS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; LEG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; REGISTER; SEX RATIO; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; AWARENESS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; NETHERLANDS; PATIENT ADMISSION; PATIENT EDUCATION AS TOPIC; PERIPHERAL VASCULAR DISEASES; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 70349869020     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-9-43     Document Type: Article

References (47)

1. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003, 163(8):884-92. 10.1001/archinte.163.8.884, 12719196.
2. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 1990, 81(2):602-9.
3. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006, 113(11):e463-e654. 10.1161/CIRCULATIONAHA.106.174526, 16549646.
4. Dormandy J, Heeck L, Vig S. The fate of patients with critical leg ischemia. Semin Vasc Surg 1999, 12(2):142-7.
5. Jelnes R, Gaardsting O, Hougaard JK, Baekgaard N, Tonnesen KH, Schroeder T. Fate in intermittent claudication: outcome and risk factors. Br Med J (Clin Res Ed) 1986, 293(6555):1137-40. 10.1136/bmj.293.6555.1137, 1341850, 3094806.
6. Fowkes FG. Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg 1988, 2(5):283-91. 10.1016/S0950-821X(88)80002-1, 3069497.
7. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol 1992, 45(5):529-42. 10.1016/0895-4356(92)90102-S, 1588358.
8. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992, 326(6):381-6.
9. Hughson WG, Mann JI, Garrod A. Intermittent claudication: prevalence and risk factors. Br Med J 1978, 1(6124):1379-81. 10.1136/bmj.1.6124.1379, 1604804, 647301.
10. McDermott MM, Mandapat AL, Moates A, Albay M, Chiou E, Celic L. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease. Arch Intern Med 2003, 163(18):2157-62. 10.1001/archinte.163.18.2157, 14557213.
11. Cacoub PP, Abola MT, Baumgartner I, Bhatt DL, Creager MA, Liau CS. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis 2009, 204(2):e86-92. 10.1016/j.atherosclerosis.2008.10.023, 19054514.
12. Bowlin SJ, Medalie JH, Flocke SA, Zyzanski SJ, Goldbourt U. Epidemiology of intermittent claudication in middle-aged men. Am J Epidemiol 1994, 140(5):418-30.
13. Caro J, Migliaccio-Walle K, Ishak KJ, Proskorovsky I. The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord 2005, 5:14. 10.1186/1471-2261-5-14, 1183197, 15972099.
14. Feringa HH, Bax JJ, Hoeks S, van WV, Elhendy A, Karagiannis S. A prognostic risk index for long-term mortality in patients with peripheral arterial disease. Arch Intern Med 2007, 167(22):2482-9. 10.1001/archinte.167.22.2482, 18071171.
15. Leng GC, Lee AJ, Fowkes FG, Whiteman M, Dunbar J, Housley E. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996, 25(6):1172-81. 10.1093/ije/25.6.1172, 9027521.
16. McDermott MM, Tian L, Liu K, Guralnik JM, Ferrucci L, Tan J. Prognostic value of functional performance for mortality in patients with peripheral artery disease. J Am Coll Cardiol 2008, 51(15):1482-9. 10.1016/j.jacc.2007.12.034, 2459324, 18402904.
17. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation 1990, 82(6):1925-31.
18. Koek HL, de BA, Gast F, Gevers E, Kardaun JW, Reitsma JB. Short- and long-term prognosis after acute myocardial infarction in men versus women. Am J Cardiol 2006, 98(8):993-9. 10.1016/j.amjcard.2006.05.016, 17027558.
19. Vaartjes I, Reitsma JB, de BA, Berger-van SM, Bos MJ, Breteler MM. Nationwide incidence of first stroke and TIA in the Netherlands. Eur J Neurol 2008, 15(12):1315-23. 10.1111/j.1468-1331.2008.02309.x, 19049548.
20. The International Statistical Classification of Diseases, Injuries and Causes of Death. Ninth Revision. Clinical Modification 1979, Washington DC: U.S, World Health Organization.
21. International Statistical Classification of Diseases and Related Health Problems. Tenth revision 1992, Geneva, World Health Organization.
22. Reitsma JB, Kardaun JW, Gevers E, de BA, van der WJ, Bonsel GJ. [Possibilities for anonymous follow-up studies of patients in Dutch national medical registrations using the Municipal Population Register: a pilot study]. Ned Tijdschr Geneeskd 2003, 147(46):2286-90.
23. Brevetti G, Diehm C, Lambert D. European multicenter study on propionyl-L-carnitine in intermittent claudication. J Am Coll Cardiol 1999, 34(5):1618-24. 10.1016/S0735-1097(99)00373-3, 10551714.
24. Hiatt WR, Klepack E, Nehler M, Regensteiner JG, Blue J, Imus J. The effect of inhibition of acyl coenzyme A-cholesterol acyltransferase (ACAT) on exercise performance in patients with peripheral arterial disease. Vasc Med 2004, 9(4):271-7. 10.1191/1358863x04vm569oa, 15678619.
25. Mohler ER, Hiatt WR, Olin JW, Wade M, Jeffs R, Hirsch AT. Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial. J Am Coll Cardiol 2003, 41(10):1679-86. 10.1016/S0735-1097(03)00299-7, 12767646.
26. Brass EP, Hiatt WR. Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies. Vasc Med 2006, 11(3):141-5. 10.1177/1358863x06069513, 17288119.
27. Hultgren R, Olofsson P, Wahlberg E. Gender differences in patients treated for critical limb ischemia. Eur J Vasc Endovasc Surg 2005, 29(3):295-300. 10.1016/j.ejvs.2004.12.010, 15694804.
28. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991, 87(2-3):119-28. 10.1016/0021-9150(91)90014-T, 1854359.
29. Diehm C, Lange S, Darius H, Pittrow D, von SB, Tepohl G. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006, 27(14):1743-9. 10.1093/eurheartj/ehl092, 16782720.
30. Diehm C, Darius H, Burghaus I, Mahn M, Pittrow D. Ankle brachial index vs metabolic syndrome for risk prediction. Lancet 2008, 372(9645):1221-2. 10.1016/S0140-6736(08)61517-2, 19094953.
31. Vaartjes I, Reitsma JB, Berger-van Sijl M, Bots ML. Gender differences in mortality after hospital admission for stroke. Accepted for publication in Cerebr Dis 2009,
32. Hirsch AT, Murphy TP, Lovell MB, Twillman G, Treat-Jacobson D, Harwood EM. Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey. Circulation 2007, 116(18):2086-94. 10.1161/CIRCULATIONAHA.107.725101, 17875966.
33. Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA. Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart 2009, 30(2):192-201.
34. Watson K, Watson BD, Pater KS. Peripheral arterial disease: a review of disease awareness and management. Am J Geriatr Pharmacother 2006, 4(4):365-79. 10.1016/j.amjopharm.2006.12.006, 17296541.
35. Mackenbach JP, van Duyne WM, Kelson MC. Certification and coding of two underlying causes of death in The Netherlands and other countries of the European Community. J Epidemiol Community Health 1987, 41(2):156-60. 10.1136/jech.41.2.156, 1052602, 3655636.
36. Paas GRA, Veenhuizen KCW. Research on the validity of the LMR: [In Dutch]. Utrecht: Prismant 2002,
37. De Bruin A, Kardaun JWPF, Gast A. Record linkage of hospital discharge register with population register: experiences at Statistics Netherlands. Statistical Journal of the United Nations Economic Commission for Europe 2004, 21:23-32.
38. Sethi A, Arora RR. Medical management and cardiovascular risk reduction in peripheral arterial disease. Exp Clin Cardiol 2008, 13(3):113-9. 2586407, 19343125.
39. Gardner AW, Montgomery PS, Parker DE. Physical activity is a predictor of all-cause mortality in patients with intermittent claudication. J Vasc Surg 2008, 47(1):117-22. 10.1016/j.jvs.2007.09.033, 2701190, 18178462.
40. Reiss AB, Edelman SD. Recent insights into the role of prostanoids in atherosclerotic vascular disease. Curr Vasc Pharmacol 2006, 4(4):395-408. 10.2174/157016106778521652, 17073704.
41. Pasqualini L, Schillaci G, Pirro M, Vaudo G, Siepi D, Innocente S. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease. J Intern Med 2007, 262(6):668-77. 10.1111/j.1365-2796.2007.01863.x, 17908164.
42. Ingolfsson IO, Sigurdsson G, Sigvaldason H, Thorgeirsson G, Sigfusson N. A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterol-the Reykjavik Study. J Clin Epidemiol 1994, 47(11):1237-43. 10.1016/0895-4356(94)90128-7, 7722559.
43. Jensen SA, Vatten LJ, Nilsen TI, Romundstad PR, Myhre HO. The association between smoking and the prevalence of intermittent claudication. Vasc Med 2005, 10(4):257-63. 10.1191/1358863x05vm635oa, 16444854.
44. Meru AV, Mittra S, Thyagarajan B, Chugh A. Intermittent claudication: an overview. Atherosclerosis 2006, 187(2):221-37. 10.1016/j.atherosclerosis.2005.11.027, 16386260.
45. Giskes K, Kunst AE, Benach J, Borrell C, Costa G, Dahl E. Trends in smoking behaviour between 1985 and 2000 in nine European countries by education. J Epidemiol Community Health 2005, 59(5):395-401. 10.1136/jech.2004.025684, 1733079, 15831689.
46. Khan S, Cleanthis M, Smout J, Flather M, Stansby G. Life-style modification in peripheral arterial disease. Eur J Vasc Endovasc Surg 2005, 29(1):2-9. 10.1016/j.ejvs.2004.09.020, 15570264.
47. Statline. Statistics Netherlands 2009, , http://statline.cbs.nl/statweb/